Abbott, Dexcom grapple with diabetes coverage ahead of planned Medicare expansion

T2Covered by 1 source · first reported by BioPharma Dive / Healthcare Dive / MedTech Dive at 02 Nov, 16:35 UTC

Abbott said it is facing pricing pressure and slower growth ahead of a planned coverage expansion for people with Type 2 diabetes. Competitor Dexcom, however, did not experience the same slowdown.